MetLife Small Company Equity Inst holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
MetLife Small Company Equity Fund Institutional Shares MSVIX
- NAV / 1-Day Return 5.46 / −0.73 %
- Total Assets 7.7M
-
Adj. Expense Ratio
0.990%
- Expense Ratio 0.980%
- Distribution Fee Level Above Average
- Share Class Type Institutional
- Category Small Blend
- Investment Style Small Blend
- Min. Initial Investment 100,000
- Status Open
- TTM Yield 0.08%
- Turnover 90%
USD | NAV as of Jul 14, 2026 | 1-Day Return as of Jul 14, 2026, 12:11 AM GMT+0
Morningstar’s Analysis MSVIX
Will MSVIX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 17.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Cash & Cash Equivalents | 4.79 | 337,645 | Cash and Equivalents |
Axsome Therapeutics Inc | 1.92 | 135,723 | Healthcare |
Kontoor Brands Inc | 1.89 | 133,410 | Consumer Cyclical |
Advanced Energy Industries Inc | 1.81 | 127,470 | Industrials |
Littelfuse Inc | 1.79 | 125,899 | Technology |
Northwest Natural Holding Co | 1.75 | 123,204 | Utilities |
Plexus Corp | 1.73 | 121,929 | Technology |
State Street® SPDR® S&P® Biotech ETF | 1.71 | 120,322 | — |
Praxis Precision Medicines Inc Ordinary Shares | 1.70 | 119,532 | Healthcare |
iShares Russell 2000 ETF | 1.60 | 112,840 | — |